The American Stroke Association is pleased to recognize Bayer® Aspirin as a national sponsor of the American Stroke Association’s Together to End Stroke initiative. Through its Secondary Stroke Prevention campaign, the ASA and Bayer Aspirin will work together to reduce stroke reoccurrence, reduce 30-day readmissions, increase stroke patient knowledge of the risk factors and educate people on the benefits of aspirin and other medications, plus healthy behaviors, as recommended by physicians to reduce stroke reoccurrence.
